ApoE-/-/Lysozyme MEGFP/EGFP mice as a versatile model to study monocyte and neutrophil trafficking in atherosclerosis

Atherosclerosis

Volumn 202, Issue 1, 2009, Pages 111-118

  Rotzius, Pierre ^a   Soehnlein, Oliver ^a   Kenne, Ellinor ^a   Lindbom, Lennart ^a   Nystrom, Kristofer ^a   Thams, Sebastian ^a   Eriksson, Einar E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Atherosclerosis; Fluorescence; Intravital microscopy; Monocytes; Neutrophils

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; COLLAGEN; ENHANCED GREEN FLUORESCENT PROTEIN; LIPID; LYSOZYME; LYSOZYME M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; IMMUNOHISTOCHEMISTRY; INTRAVITAL MICROSCOPY; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; MALE; MICROSCOPY; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; HOMOZYGOTE; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; MURAMIDASE; NEUTROPHILS; REACTIVE OXYGEN SPECIES;

EID: 57649210351     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.04.009     Document Type: Article

References (28)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
2. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
4. Plump A.S., and Breslow J.L. Apolipoprotein E and the apolipoprotein E-deficient mouse. Annu Rev Nutr 15 (1995) 495-518
5. Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., and Beaudet A.L. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 191 (2000) 189-194
6. Gosling J., Slaymaker S., Gu L.., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103 (1999) 773-778
7. Nageh M.F., Sandberg E.T., Marotti K.R., et al. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 17 (1997) 1517-1520
8. Nakashima Y., Raines E.W., Plump A.S., Breslow J.L., and Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 18 (1998) 842-851
9. Yamashita T., Kawashima S., Ozaki M., et al. Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration. Arterioscler Thromb Vasc Biol 22 (2002) 969-974
10. Eriksson E.E. Leukocyte recruitment to atherosclerotic lesions, a complex web of dynamic cellular and molecular interactions. Curr Drug Targets Cardiovasc Haematol Disord 3 (2003) 309-325
11. Eriksson E.E., Xie X., Werr J., Thoren P., and Lindbom L. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J 15 (2001) 1149-1157
12. Eriksson E.E., Xie X., Werr J., Thoren P., and Lindbom L. Importance of primary capture and l-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J Exp Med 194 (2001) 205-218
13. Faust N., Varas F., Kelly L.M., Heck S., and Graf T. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood 96 (2000) 719-726
14. Markart P., Faust N., Graf T., Na C.L., Weaver T.E., and Akinbi H.T. Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P. Biochem J 380 (2004) 385-392
15. Liu H., Zheng F., Li Z., et al. Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. Am J Pathol 169 (2006) 303-313
16. Cavalleri A., Colombo C., Venturelli E., et al. Evaluation of reactive oxygen metabolites in frozen serum samples. Effect of storage and repeated thawing. Int J Biol Markers 19 (2004) 250-253
17. Iamele L., Fiocchi R., and Vernocchi A. Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med 40 (2002) 673-676
18. Burke A.P., Kolodgie F.D., Farb A., et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 103 (2001) 934-940
19. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
20. Junqueira L.C., Bignolas G., and Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11 (1979) 447-455
21. Shaposhnik Z., Wang X., Weinstein M., Bennett B.J., and Lusis A.J. Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 27 (2007) 621-627
22. Lagasse E., and Weissman I.L. Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods 197 (1996) 139-150
23. Libby P. Changing concepts of atherogenesis. J Intern Med 247 (2000) 349-358
24. Huo Y., Schober A., Forlow S.B., et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9 (2003) 61-67
25. Tacke F., Alvarez D., Kaplan T.J., et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117 (2007) 185-194
26. Van Rooijen N., and Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174 (1994) 83-93
27. Conlan J.W., and North R.J. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med 179 (1994) 259-268
28. Czuprynski C.J., Brown J.F., Maroushek N., Wagner R.D., and Steinberg H. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol 152 (1994) 1836-1846